Published in AIDS Weekly, May 26th, 1997
The approach is now being tested in humans, reported Merck researcher Margaret A. Liu in a presentation to the 9th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held May 4-7, 1997, in Bethesda, Maryland.
"The potent immunity and protection seen in these pilot experiments suggest that a DNA immunization with a DNA-plus-protein-boost regimen warrants active investigation as a vaccine strategy to prevent HIV-1 infection," Liu wrote in her presentation abstract.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.